Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Oncology Clinical Trials
Antiangiogenesis Therapy with Bevacizumab Improves Survival in Metastatic or Relapsed Cervical Cancer
Nintedanib Plus Docetaxel Improves PFS and OS for Patients with Stage IIIB/IV or Recurrent Lung Adenocarcinoma
CENTRIC Trial Results
Bevacizumab Monotherapy Improves DFI in Melanoma Patients at High Risk of Recurrence
Sequential Therapy Fails to Extend DFS in Gastric Cancer
Chemoradiotherapy Fails to Improve Overall Survival in LAPC
Treatment Based on BRCA1 and RAP80 Does Not Extend PFS
ATLAS: 10 versus 5 Years of Adjuvant Tamoxifen in ER-Positive Disease
CONFIRM Trial Final Analysis of Overall Survival: Fulvestrant 500 versus 250 mg
Neoadjuvant Chemotherapy in Women 35 and Under
Pages
Previous
Next
1
…
3
4
5
6
7
8
9
10
11